ATE435283T1 - Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen - Google Patents

Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen

Info

Publication number
ATE435283T1
ATE435283T1 AT00993009T AT00993009T ATE435283T1 AT E435283 T1 ATE435283 T1 AT E435283T1 AT 00993009 T AT00993009 T AT 00993009T AT 00993009 T AT00993009 T AT 00993009T AT E435283 T1 ATE435283 T1 AT E435283T1
Authority
AT
Austria
Prior art keywords
applications
associated antigens
nucleic acid
acid molecules
isolated nucleic
Prior art date
Application number
AT00993009T
Other languages
English (en)
Inventor
Dirk Jager
Elisabeth Stockert
Matthew Scanlan
Alexander Knuth
Lloyd Old
Ali Gure
Yao-Tseng Chen
Elke Jaeger
Original Assignee
Ludwig Inst Cancer Res
Sloan Kettering Inst Cancer
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res, Sloan Kettering Inst Cancer, Cornell Res Foundation Inc filed Critical Ludwig Inst Cancer Res
Priority claimed from PCT/US2000/042334 external-priority patent/WO2001047959A2/en
Application granted granted Critical
Publication of ATE435283T1 publication Critical patent/ATE435283T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00993009T 1999-11-30 2000-11-29 Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen ATE435283T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/451,739 US6774226B1 (en) 1999-11-30 1999-11-30 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
US09/602,362 US6911529B1 (en) 1999-11-30 2000-06-22 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
PCT/US2000/042334 WO2001047959A2 (en) 1999-11-30 2000-11-29 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

Publications (1)

Publication Number Publication Date
ATE435283T1 true ATE435283T1 (de) 2009-07-15

Family

ID=32825435

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00993009T ATE435283T1 (de) 1999-11-30 2000-11-29 Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen

Country Status (3)

Country Link
US (5) US6774226B1 (de)
AT (1) ATE435283T1 (de)
DE (1) DE60042497D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US7238471B1 (en) * 1999-11-23 2007-07-03 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating breast cancer
WO2002012563A2 (en) * 2000-08-04 2002-02-14 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
EP1390387A4 (de) * 2001-04-20 2004-12-08 Ludwig Inst Cancer Res Hodenkrebsantigene
US8921534B2 (en) * 2001-12-12 2014-12-30 Sanofi Pasteur Limited Enhancement of the immune response using CD36-binding domain
WO2004092212A2 (en) * 2003-04-15 2004-10-28 Sanofi Pasteur Limited Tumor antigens bfa5 for prevention and/or treatment of cancer
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer
US20070218480A1 (en) * 2006-01-25 2007-09-20 The Board Of Regents Of The University Of Texas System Detection and diagnosis of smoking related cancers
BRPI0818287A2 (pt) * 2007-10-08 2015-11-03 Intrexon Corp células dendríticas manipuladas e usos para o tratamento do câncer.
CN101888856B (zh) 2007-11-07 2014-08-27 塞尔德克斯医疗公司 结合人树突和上皮细胞205(dec-205)的抗体
EA201690310A1 (ru) 2010-04-13 2016-12-30 Селлдекс Терапьютикс Инк. Антитела, связывающие cd27 человека, и их применение
PE20170441A1 (es) 2014-06-06 2017-04-26 Bristol Myers Squibb Co Anticuerpos contra el receptor del factor de necrosis tumoral inducido por glucocorticoides (gitr) y sus usos
DK3303396T5 (da) 2015-05-29 2024-10-07 Bristol Myers Squibb Co Antistoffer mod ox40 og anvendelser deraf
AU2016356780A1 (en) 2015-11-19 2018-06-28 Bristol-Myers Squibb Company Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
US12297266B2 (en) 2016-04-18 2025-05-13 Celldex Therapeutics, Inc. Agonistic antibodies that bind human CD40 and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117633A (en) * 1995-12-08 2000-09-12 University Technologies International Inc. DNA sequence encoding the tumor suppressor gene ING1
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US6255470B1 (en) * 1996-10-03 2001-07-03 Memorial Sloan-Kettering Cancer Center Isolated nucleic acid molecule encoding an esophageal cancer associated antigen
AU9315698A (en) * 1997-09-11 1999-03-29 Beth Israel Deaconess Medical Center (rin2), a novel inhibitor of ras-mediated signaling
EP1117430A1 (de) * 1998-10-05 2001-07-25 Genzyme Corporation In krebszellen differentiell exprimierte gene zur herstellung von krebsimpfstoffen
US6518237B1 (en) * 1998-12-28 2003-02-11 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6844325B2 (en) * 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6590076B1 (en) * 1999-04-02 2003-07-08 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use

Also Published As

Publication number Publication date
US6911529B1 (en) 2005-06-28
US6774226B1 (en) 2004-08-10
US20080177031A1 (en) 2008-07-24
US20040126398A1 (en) 2004-07-01
US8071717B2 (en) 2011-12-06
US20100278850A1 (en) 2010-11-04
US7622568B2 (en) 2009-11-24
DE60042497D1 (de) 2009-08-13

Similar Documents

Publication Publication Date Title
ATE435283T1 (de) Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen
CY1109683T1 (el) Αντιγονα του streptococcus pyogenes
WO2001047959A3 (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
MY194997A (en) Anti-ccr7 antibody drug conjugates
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
ATE445646T1 (de) Humaner miniantikörper zytotoxisch für tumorzellen die den erbb2 rezeptor exprimieren
CN115551888A (zh) 抗cd73抗体及其用途
DE602006013029D1 (de) Anti-egfr-antikörper
ATE258379T1 (de) Nukleinsäure, die für einen tumor abstossungsantigenvorläufer kodiert
CY1116913T1 (el) Τροποποιημενα κλασματα fab αντισωματων
CY1118949T1 (el) Ανθρωπινα αντισωματα που προσδενουν cxcr4 και χρησεις αυτων
ATE414535T1 (de) Trägerproteine für impfstoffe
TW200510459A (en) RG1 antibodies and uses thereof
CY1118462T1 (el) Μονοκλωνικο αντισωμα κατα της πρωτεϊνης συνδεσης οστεοπροτεγερινης
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
DE60329489D1 (de) Fusionsproteine humanisierter g250-spezifischer antikörper sowie verwendungen davon
TR201901841T4 (tr) Her antikorlarının sabit dozlaması.
DE60321041D1 (de) Antikörper gegen krebsantigen tmeff2 und seine anwendungen
BRPI0416141B8 (pt) anticorpo anti-cd52 modificado, composição farmacêutica, vetores de expressão, e método para preparar uma imunoglobulina
EP2275435A3 (de) Streptococcus agalactiae antigene I + II
WO2003050243A3 (en) Novel genes encoding colon cancer antigens
WO2022170280A3 (en) Novel anti-cd24 antibodies
SG146644A1 (en) Kid3 and kid3 antibodies that bind thereto
MX2010001237A (es) Nuevos anticuerpos.
WO2003064593A3 (en) Antigen panels and methods of using the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1261704

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1261704

Country of ref document: EP